BioSpace News Archive

Pharmaceutical Lipids Market: Development in drug delivery technology is working as a driver for the market growth

The global pharmaceutical lipids market is foreseen to grow at significant rate during the forecast period of 2020 to 2030.

October 14, 2020
·
4 min read
Bioavailability Enhancers Market: Plant based segment generates a higher revenue

Bioavailability enhancer is an agent that is combined with a drug to increase the bioefficacy and bioavailability of the drug.

October 14, 2020
·
5 min read
Policy

Moberg Pharma intends to submit a registration application in Europe in 2021

Moberg Pharma AB announced its decision to request pre-submission meetings with regulatory agencies, with the goal of submitting a registration application in the second half of 2021 in Europe.

October 14, 2020
·
3 min read
Business

AffaMed Therapeutics Announces Merger with EverInsight Therapeutics and Appoints Dayao Zhao, M.D., Ph.D. as CEO

Combined company led by Dr. Zhao creates robust and potentially first-in-class pipeline of drug candidates in growing ophthalmology and CNS markets

October 14, 2020
·
6 min read
Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.com

Aurinia Pharmaceuticals Inc. announced Time Is Nephrons, the first-ever lupus nephritis disease-state awareness campaign for healthcare professionals.

October 14, 2020
·
6 min read
Drug Development

Evelo Biosciences Completes Enrollment in Phase 1b Clinical Trial Cohort Evaluating EDP1815 in Atopic Dermatitis–Data expected in 1Q 2021

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, announced that it has completed enrollment of 24 patients in the Phase 1b clinical trial cohort evaluating EDP1815 in mild to moderate atopic dermatitis.

October 14, 2020
·
8 min read
Pharm Country

Arvinas Announces Pipeline Programs Targeting Validated and Classically “Undruggable” Disease-Causing Proteins

Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced platform updates and disclosed five additional programs from its preclinical pipeline.

October 14, 2020
·
6 min read
Sleep Aids Market | High Prevalence of Sleep Disorders to Contribute toward Spiraling Demand in the Market

Sleep aids refer to those medical devices and drugs that are utilized in the diagnosis and treatment of various types of sleep disorders, including insomnia and sleep apnea.

October 14, 2020
·
3 min read
DNA Sequencing Market has witnessed a Rapid Growth Momentum | TMR Research Study

Since the last decade, technologies and techniques for rapid sequencing of human genomes have made incredible strides.

October 14, 2020
·
4 min read
Drug Development

Aliqopa™ (copanlisib) in Combination With Rituximab Meets Primary Endpoint in Patients With Relapsed Indolent Non-Hodgkin’s Lymphoma

Phase III study CHRONOS-3 in patients with relapsed indolent Non-Hodgkin’s Lymphoma (iNHL) who have received one or more prior lines of rituximab-containing therapy meets primary endpoint of progression-free survival

October 14, 2020
·
12 min read